Press Release: Novo Nordisk’s Wegovy® cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular diseas
Bagsværd, Denmark, 31 August 2025 – Novo Nordisk today presented data from the STEER real-world study of evidence gathered from actual patient experiences at the European Society of Cardiology (ESC) Congress 2025 in Madrid, Spain. The STEER study investigated the risk of major adverse cardiovascular events (MACE) with Wegovy® (semaglutide 2.4 mg) compared with tirzepatide…
NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that clinical data from its ongoing Phase 2 study of SLS009, a highly selective CDK9…
MANILA, Philippines, Dec. 08, 2025 (GLOBE NEWSWIRE) -- A damning analysis from the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), entitled "The FCTC Secretariat's Deepening Legitimacy Problem", exposes how the World Health Organization's Framework Convention on Tobacco Control has been captured by American philanthropist-funded NGOs, fundamentally undermining the treaty's credibility and harming global public…
NEW YORK, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Marex Group plc (“Marex” or “the Company”) (NASDAQ: MRX) and certain of its officers.
Austin, Texas, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Autism Spectrum Disorder Market Size & Growth Analysis According to SNS Insider, the Autism Spectrum Disorder Market size is estimated at USD 2.06 billion in 2025 and is expected to reach USD 4.07 billion by 2033, growing at a CAGR of 8.89% over 2026-2033. The Autism Spectrum…
DUBAI, United Arab Emirates, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Mutuum Finance (MUTM), a developing decentralized lending protocol, has announced the successful completion of all Phase 1 roadmap milestones and confirmed that Phase 2 is already more than halfway complete. With rapid development progress, expanding community engagement, and an accelerating presale, the project is building…
